Therefore, NT labelled with radioactive isotopes or cytostatic drugs, as well as specific anti-S1P or anti-GDF-15 antibodies or some of the aforementioned anti-cancer drugs, are ineffective in GBM therapy [507]. This evidence concerns the gene MBTPS1 and cancer.